Bicycle Therapeutics Plc (BCYC)
4.30
+0.06
(+1.42%)
USD |
NASDAQ |
Sep 04, 16:00
4.295
0.00 (0.00%)
After-Hours: 20:00
Bicycle Therapeutics SG&A Expense (TTM) : 71.10M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 71.10M |
| March 31, 2026 | 75.75M |
| December 31, 2025 | 79.52M |
| September 30, 2025 | 80.05M |
| June 30, 2025 | 79.75M |
| March 31, 2025 | 77.01M |
| December 31, 2024 | 72.18M |
| September 30, 2024 | 65.78M |
| June 30, 2024 | 63.52M |
| March 31, 2024 | 62.39M |
| December 31, 2023 | 60.64M |
| September 30, 2023 | 56.40M |
| June 30, 2023 | 50.17M |
| March 31, 2023 | 47.06M |
| December 31, 2022 | 49.30M |
| September 30, 2022 | 47.39M |
| June 30, 2022 | 45.51M |
| March 31, 2022 | 41.12M |
| Date | Value |
|---|---|
| December 31, 2021 | 32.42M |
| September 30, 2021 | 34.51M |
| June 30, 2021 | 33.72M |
| March 31, 2021 | 32.60M |
| December 31, 2020 | 29.44M |
| September 30, 2020 | 21.94M |
| June 30, 2020 | 19.41M |
| March 31, 2020 | 16.16M |
| December 31, 2019 | 14.60M |
| September 30, 2019 | 13.37M |
| June 30, 2019 | 10.94M |
| March 31, 2019 | 9.664M |
| December 31, 2018 | 8.227M |
| September 30, 2018 | 8.554M |
| June 30, 2018 | 6.226M |
| March 31, 2018 | 4.545M |
| December 31, 2017 | 2.543M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Autolus Therapeutics Plc | 152.92M |
| Biodexa Pharmaceuticals Plc | 6.375M |
| Akari Therapeutics Plc | 8.796M |
| DBV Technologies SA | 56.62M |
| Cellectis SA | 21.32M |